MedPath

Jail-Based Use of Smoking Cessation Treatment Study

Not Applicable
Completed
Conditions
Tobacco Use
Interventions
Registration Number
NCT03799315
Lead Sponsor
Hennepin Healthcare Research Institute
Brief Summary

Smoking rates remain above 60% for individuals involved in the criminal justice system and contribute to elevated mortality rates in this population. Addressing smoking disparities among justice-involved individuals is a critical public health issue in Minnesota, one of a few states with rising incarceration rates. People who are incarcerated represent the intersection of multiple high-priority populations (disproportionately African-American, Native American, low-income, homeless, on Medicaid, and suffering from mental illness and substance use disorders). This study examines the impact of a smoking cessation intervention for individuals discharged from jail to the community on smoking abstinence. Participants will be randomized to either 1) guideline-based, in-person smoking cessation counseling during incarceration, telephone counseling after incarceration, and nicotine replacement, or 2) enhanced treatment as usual. This study's findings will be used to develop a larger, multi-site study that is fully powered to measure longer-term health and smoking cessation outcomes.

Detailed Description

Outcome assessments will be conducted for both arms at 1 week, 3 weeks, and 12 weeks post discharge from jail. During these assessments, seven-day point prevalence abstinence will be bio-verified with exhaled carbon monoxide, and self-reported general health, physical health, mental health, and substance use measures will also be obtained. The analysis is fully powered (i.e., power \> .8) to detect significant between group effects on the primary outcome (i.e., the longitudinal, between group effect on bio-verified seven-day point prevalence abstinence over the 3 weeks post discharge). All analyses will be conducted on the intent to treat sample and will utilize pre-specified logistic and linear regression models.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • Use of ≥ 1 cigarette per day prior to incarceration
  • Expected release from the Hennepin Adult Detention Center to the community within 90 days
  • Age 18-64
  • English fluency
  • Lives within 20 minutes of Hennepin County Medical Center and has no plans to move away from area for 4 months
  • Willing to attempt quitting or reducing smoking at discharge
  • Has a telephone
  • Cleared for nicotine lozenge safety by jail health care provider and willing to use at discharge
Exclusion Criteria
  • Active tuberculosis
  • Current mental health crisis (i.e., currently experiencing significant mania, psychosis, or suicidality)
  • Unable to ambulate independently
  • Acute medical condition that would impair participant's ability to follow-up for assessments
  • Expected discharge to a control institutional setting (e.g., locked state mental health facility or prison)
  • Active pregnancy
  • Heart attack within the last two weeks

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Jail-Based Use of Smoking Cessation Treatment (JUST)Nicotine Replacement TherapyParticipants will receive guidline-based smoking cessation counseling while in jail and phone-based smoking cessation counseling sessions and nicotine lozenges after release from jail.
Jail-Based Use of Smoking Cessation Treatment (JUST)CounselingParticipants will receive guidline-based smoking cessation counseling while in jail and phone-based smoking cessation counseling sessions and nicotine lozenges after release from jail.
Primary Outcome Measures
NameTimeMethod
Bioverified 7-day point prevalence abstinence from smokingOver 3 weeks

Bioverified 7-day point prevalence abstinence from smoking

Secondary Outcome Measures
NameTimeMethod
Time to Lapse1 week, 3 weeks, 12 weeks

Days to first lapse (i.e., any cigarette use, even a puff)

Bio-verified 7-day point prevalence abstinence from smokingOver 12 weeks

Bioverified 7-day point prevalence abstinence from smoking

Health-related quality of life1 week, 3 weeks, 12 weeks

Self-Reported health using the SF-12 total score and physical and mental health composite scores. Lower scores indicate worse health.

Depressive symptoms1 week, 3 weeks, 12 weeks

The 10 item Center for Epidemiologic Studies Depression Scale (CESD-10) ranges from 0-30 with higher scores indicating higher depression symptoms.

Substance abuse1 week, 3 weeks, 12 weeks

Self-reported substance abuse using the Drug Abuse Screening Test-10. Higher scores indicate more severe drug abuse.

Health care utilization1 week, 3 weeks, 12 weeks

Self-reported hospitalizations and use of the emergency department

Time to Relapse3 weeks, 12 weeks

Days to first relapse

Self-Reported Affect1 week, 3 weeks, 12 weeks

10-item Positive and Negative Affect Scales (PANAS). The 5-item positive affect scale on the PANAS ranges from 5-25 with higher scores indicating greater positive affect. The 5-item negative affect scale on the PANAS ranges from 5-25 with higher scores indicating greater negative affect.

Trial Locations

Locations (1)

Hennepin Healthcare Research Institute

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath